MedPath

Permethrin and Ivermectin in the Scabies Treatment

Not Applicable
Conditions
Scabies.
Scabies
Registration Number
IRCT20221222056891N1
Lead Sponsor
Pak Emirates Military Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients above 5 years of age and more than 15 kg of weight
Both genders
Patients having scabies as per operational definition

Exclusion Criteria

Patient treated with any scabicidal therapy in the last 01 month
Patients taking any topical or systemic antibiotic therapy in the week before entry into the study
H/o allergy to any of the study drugs
Immunologically-compromised patients
Pregnancy in women
Crusted/Norwegian scabies
H/o secondary bacterial infection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pruritus. Timepoint: At the time of treatment and at 1st, 2nd and 4th week after intervention. Method of measurement: History for pruritus (relieved/not relieved).;Scabietic Lesions (Burrows and Papules). Timepoint: At the time of treatment and at 1st, 2nd and 4th week after intervention. Method of measurement: Clinical Examination and Dermoscopy for scabietic lesions (present/not present).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath